ELOCTATE IV 1000, from Sanofi, contains Efflaloctocog alpha (genetically recombination), a recombinant Factor VIII product for the control and prevention of bleeding episodes and perioperative management in hemophilia A. It is supplied as 1,000 IU 1 bottle with dissolving liquid (YJ code: 6343442D4021).
ELOCTATE IV 1000
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).